Here's Why China National Accord Medicines (SZSE:000028) Can Manage Its Debt Responsibly
Jan 22
Have your own idea? Try our Stock Screener
Chinese (SSE) Healthcare Services Industry Analysis
UpdatedJan 30, 2025
DataAggregated Company Financials
Companies40
- 7D1.0%
- 3M-8.0%
- 1Y-3.6%
- YTD-2.3%
The Healthcare Services is pretty flat in the last 7 days, but Shanghai Pharmaceuticals Holding has stood out, gaining 3.4%. Unfortunately though, the industry is down 6.5% over the past 12 months. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the Chinese Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 30 Jan 2025 | CN¥547.2b | CN¥994.3b | CN¥21.5b | 28.6x | 25.4x | 0.6x |
| Sat, 28 Dec 2024 | CN¥599.0b | CN¥994.3b | CN¥21.5b | 32.1x | 27.8x | 0.6x |
| Mon, 25 Nov 2024 | CN¥605.5b | CN¥994.3b | CN¥21.5b | 32.8x | 28.1x | 0.6x |
| Wed, 23 Oct 2024 | CN¥604.2b | CN¥985.0b | CN¥22.0b | 36.1x | 27.4x | 0.6x |
| Fri, 20 Sep 2024 | CN¥468.7b | CN¥984.5b | CN¥22.0b | 26.4x | 21.3x | 0.5x |
| Sun, 18 Aug 2024 | CN¥510.2b | CN¥988.6b | CN¥22.6b | 27.6x | 22.5x | 0.5x |
| Tue, 16 Jul 2024 | CN¥493.8b | CN¥988.5b | CN¥22.5b | 27.7x | 21.9x | 0.5x |
| Thu, 13 Jun 2024 | CN¥549.9b | CN¥988.5b | CN¥22.5b | 30.8x | 24.4x | 0.6x |
| Sat, 11 May 2024 | CN¥598.5b | CN¥988.3b | CN¥22.4b | 34.3x | 26.7x | 0.6x |
| Mon, 08 Apr 2024 | CN¥594.3b | CN¥986.0b | CN¥19.4b | 29.3x | 30.6x | 0.6x |
| Wed, 06 Mar 2024 | CN¥621.7b | CN¥977.8b | CN¥20.1b | 30x | 30.9x | 0.6x |
| Fri, 02 Feb 2024 | CN¥572.4b | CN¥976.6b | CN¥19.8b | 28.3x | 28.9x | 0.6x |
| Sun, 31 Dec 2023 | CN¥678.0b | CN¥976.1b | CN¥19.9b | 33.3x | 34x | 0.7x |
| Tue, 28 Nov 2023 | CN¥717.8b | CN¥976.1b | CN¥19.9b | 32.2x | 36x | 0.7x |
| Thu, 26 Oct 2023 | CN¥681.4b | CN¥982.3b | CN¥21.0b | 27.2x | 32.4x | 0.7x |
| Sat, 23 Sep 2023 | CN¥724.3b | CN¥982.2b | CN¥21.2b | 29.5x | 34.2x | 0.7x |
| Mon, 21 Aug 2023 | CN¥729.1b | CN¥956.6b | CN¥23.2b | 24.1x | 31.4x | 0.8x |
| Wed, 19 Jul 2023 | CN¥771.8b | CN¥948.1b | CN¥23.0b | 25.5x | 33.6x | 0.8x |
| Fri, 16 Jun 2023 | CN¥804.0b | CN¥948.0b | CN¥23.0b | 26.8x | 35x | 0.8x |
| Sun, 14 May 2023 | CN¥828.6b | CN¥947.9b | CN¥22.9b | 26.2x | 36.1x | 0.9x |
| Tue, 11 Apr 2023 | CN¥847.0b | CN¥909.7b | CN¥26.9b | 31.3x | 31.5x | 0.9x |
| Thu, 09 Mar 2023 | CN¥837.6b | CN¥906.6b | CN¥26.4b | 30.7x | 31.7x | 0.9x |
| Sat, 04 Feb 2023 | CN¥854.2b | CN¥906.0b | CN¥26.4b | 29.2x | 32.4x | 0.9x |
| Mon, 02 Jan 2023 | CN¥803.3b | CN¥905.7b | CN¥26.4b | 28.3x | 30.5x | 0.9x |
| Wed, 30 Nov 2022 | CN¥765.6b | CN¥905.7b | CN¥26.4b | 30.2x | 29x | 0.8x |
| Fri, 28 Oct 2022 | CN¥667.5b | CN¥856.1b | CN¥24.4b | 24.3x | 27.3x | 0.8x |
| Sun, 25 Sep 2022 | CN¥625.0b | CN¥842.5b | CN¥23.8b | 20.1x | 26.2x | 0.7x |
| Tue, 23 Aug 2022 | CN¥683.5b | CN¥837.3b | CN¥22.9b | 31.1x | 29.9x | 0.8x |
| Thu, 21 Jul 2022 | CN¥778.4b | CN¥840.7b | CN¥24.0b | 31.2x | 32.4x | 0.9x |
| Sat, 18 Jun 2022 | CN¥716.2b | CN¥839.0b | CN¥23.9b | 24.8x | 29.9x | 0.9x |
| Mon, 16 May 2022 | CN¥689.9b | CN¥839.0b | CN¥23.9b | 26.1x | 28.8x | 0.8x |
| Wed, 13 Apr 2022 | CN¥657.3b | CN¥820.1b | CN¥28.2b | 27.4x | 23.3x | 0.8x |
| Fri, 11 Mar 2022 | CN¥647.2b | CN¥806.8b | CN¥26.8b | 26.9x | 24.2x | 0.8x |
| Sun, 06 Feb 2022 | CN¥634.6b | CN¥805.6b | CN¥26.7b | 23.8x | 23.8x | 0.8x |
Price to Earnings Ratio
23.8x
Current Industry PE
- Investors are pessimistic on the Chinese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 25.4x which is lower than its 3-year average PE of 29.4x.
- The industry is trading close to its 3-year average PS ratio of 0.74x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 7.0% per year over the last three years.
- Meanwhile revenues for these companies have grown 7.3% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | 0.066% | |
| Healthcare | 0.19% | |
| Healthcare Services | 1.01% | |
| Healthcare Distributors | 1.62% | |
| Healthcare Services | 0.50% | |
| Healthcare Facilities | 0.17% | |
| Managed Healthcare | 0% | 0 |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 39.0x.
- Analysts are expecting annual earnings growth of 38.2%, which is higher than its past year's earnings decline of 10.6% per year.
- Investors are most pessimistic about the Healthcare Distributors industry, which is trading close to its 3-year average of 18.7x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 38% over the next 5 years.
- This is better than its past earnings decline of 11% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 16% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 601607 Shanghai Pharmaceuticals Holding | CN¥20.15 | 3.5% +CN¥2.5b | 18.9% | PE18.6x | |
| 600511 China National Medicines | CN¥32.25 | 3.7% +CN¥875.2m | 7.9% | PE11.2x | |
| 000963 Huadong Medicine | CN¥34.80 | 1.1% +CN¥665.0m | 20.2% | PE19x | |
| 002044 Meinian Onehealth Healthcare Holdings | CN¥4.36 | 1.9% +CN¥311.2m | -10.7% | PE55.2x | |
| 301015 Qingdao Baheal Medical | CN¥23.29 | 2.5% +CN¥299.6m | -19.5% | PE17.4x |
